BREAKING NEWS: Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy

Press Release: https://ir.plustherapeutics.com/news-releases/news-release-details/plus-therapeutics-and-spectronrx-announce-radiotherapeutic